Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly and the primary cause in industrialized countries. With an increase in life expectancy, age-related eye diseases such as AMD and cataract are more prevalent and adequate treatment options are required to maintain quality of life. AMD affects the macula, a region 5-6 mm in diameter in the posterior pole of the retina that is responsible for sharp central vision. Dry AMD accounts for 90% of the cases and can advance slowly to advanced dry AMD or wet AMD (also known as choroidal neovascularization or exudative AMD). There are treatment options for wet AMD which delay AMD progression but none for dry AMD. Nutritional interventions are part of the efforts for preventing progression of dry AMD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
